Can metastatic cancer causing facial asymmetry be detected with a noncontrast Magnetic Resonance Imaging (MRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Metastatic Cancer Causing Facial Asymmetry Be Detected on Noncontrast MRI?

Yes, noncontrast MRI can detect metastatic cancer causing facial asymmetry, but contrast-enhanced MRI is significantly superior and should be used whenever possible. While noncontrast MR sequences are routinely used to identify tumors and can define tumor extent—particularly marrow involvement and nodal disease—the absence of IV contrast substantially limits the ability to accurately delineate tumor margins and soft tissue extent 1.

Why Noncontrast MRI Has Limited Utility

The fundamental limitation is that noncontrast imaging cannot reliably distinguish tumor from surrounding normal soft tissues or treatment-related changes. 1

  • Noncontrast sequences can identify the presence of a mass and assess marrow involvement, which is valuable for detecting bone metastases 1
  • However, accurate delineation of soft tissue tumor margins—critical for determining the cause of facial asymmetry—requires contrast enhancement 1
  • The soft tissue contrast resolution advantage of MRI over CT is largely negated without IV contrast administration 1

What Noncontrast MRI Can Detect

Noncontrast MR sequences have specific but limited capabilities:

  • Bone marrow metastases are well-visualized on noncontrast sequences, appearing as abnormal signal replacing normal marrow fat 1
  • Large soft tissue masses causing obvious facial asymmetry may be identifiable, though their exact extent and margins remain poorly defined 1
  • Nodal metastases can be assessed based on size and morphology criteria on noncontrast imaging 1

The Critical Advantage of Contrast-Enhanced MRI

MRI orbits, face, and neck without and with IV contrast provides superior soft tissue contrast resolution that is essential for accurate tumor delineation. 1

Key advantages include:

  • Distinguishing tumor from normal tissues: Contrast enhancement allows clear demarcation of tumor margins from surrounding soft tissues 1
  • Detecting perineural spread: This critical feature of certain malignancies (particularly adenoid cystic carcinoma) is best identified with contrast-enhanced sequences 1, 2
  • Identifying skull base and intracranial extension: Contrast is essential for detecting subtle invasion of adjacent structures 1
  • Detecting deep-seated tumors: MRI with contrast has detected up to 27.8% of deep-seated recurrences that were occult on clinical examination 1

Clinical Algorithm for Facial Asymmetry Evaluation

When metastatic cancer is suspected as the cause of facial asymmetry:

  1. First-line imaging should be MRI orbits, face, and neck without and with IV contrast 1, 2, 3

    • This provides comprehensive evaluation from orbits through neck in a single examination 3
    • Superior for detecting salivary gland tumors (the most common slow-growing cancers causing facial asymmetry) 2
  2. If contrast is contraindicated, noncontrast MRI can be performed but with the understanding that:

    • Tumor margins will be poorly defined 1
    • Soft tissue extent cannot be accurately assessed 1
    • Follow-up with FDG-PET/CT may be necessary for complete evaluation 1
  3. CT neck with IV contrast is an acceptable alternative when MRI is contraindicated or unavailable 2, 4

    • Particularly useful for evaluating osseous anatomy and cortical bone destruction 1
    • Less susceptible to motion artifact than MRI 1

Common Pitfalls to Avoid

  • Do not order "MRI head" when evaluating facial asymmetry—this does not adequately cover the face or orbits and will miss facial pathology 3
  • Do not rely on noncontrast imaging alone when malignancy is suspected, as this significantly reduces diagnostic accuracy from 74-77% with contrast to much lower sensitivity 4
  • Do not assume all facial asymmetry from cancer will be obvious—subtle perineural spread and early marrow involvement may be the only findings 1, 2

Specific Cancers Causing Facial Asymmetry

Salivary gland tumors are the primary consideration for slow-growing cancers causing progressive facial asymmetry: 2

  • Pleomorphic adenoma (most common, benign) presents as painless slow-growing mass 2
  • Adenoid cystic carcinoma is notorious for perineural spread, which may cause facial weakness but can be asymptomatic early 2
  • These tumors require contrast-enhanced MRI for optimal detection and characterization 2

Metastatic disease to facial bones (from breast, lung, kidney, thyroid primaries) typically causes:

  • Bone marrow replacement visible on noncontrast sequences 5
  • Cortical destruction better seen on CT 5
  • Associated soft tissue mass requiring contrast for full delineation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Slow-Growing Cancers Causing Progressive Facial Asymmetry

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MRI Orbits, Face, and Neck Imaging Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contrast-Enhanced CT in Cancer Detection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The diagnostic imaging of bone metastases.

Deutsches Arzteblatt international, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.